Table 3.
Liver enzymes and lipid profile.
| Group | Pre | Post | Paired t-test |
Repeated ANOVA |
||||
|---|---|---|---|---|---|---|---|---|
| t | p | ES | F (T×G) |
p | ||||
| AST (U/L) | PSG (n = 18) | 22.4 ± 5.4 | 17.2 ± 3.3 | -4.573 | < .001 | 1.078 | 4.687 | .038 |
| CG (n = 16) | 19.2 ± 7.1 | 19.0 ± 7.2 | -0.090 | .929 | ||||
| ALT (U/L) | PSG (n = 18) | 27.1 ± 16.0 | 16.0 ± 6.5 | -3.638 | .002 | 0.858 | 2.382 | .230 |
| CG (n = 16) | 22.6 ± 14.1 | 20.3 ± 17.2 | -0.482 | .637 | ||||
| TC (㎎/dl) | PSG (n = 18) | 188.5 ± 23.2 | 150.8 ± 24.9 | -11.256 | < .001 | 2.653 | 1.696 | .282 |
| CG (n = 16) | 193.3 ± 23.8 | 164.1 ± 31.3 | -4.921 | < .001 | 1.230 | |||
| LDL-C (㎎/dl) | PSG (n = 18) | 110.7 ± 27.0 | 84.2 ± 25.7 | -7.349 | < .001 | 1.732 | 8.367 | .978 |
| CG (n = 16) | 119.2 ± 21.3 | 94.2 ± 28.2 | -4.799 | < .001 | 1.000 | |||
| HDL-C (㎎/dl) | PSG (n = 18) | 57.9 ± 10.3 | 51.7 ± 6.0 | -4.064 | .001 | 0.958 | 3.413 | .074 |
| CG (n = 18) | 55.1 ± 6.7 | 52.9 ± 4.4 | -1.404 | .181 | ||||
| TG (㎎/dl) | PSG (n = 16) | 84.1 ± 19.0 | 75.1 ± 25.9 | -1.142 | .271 | 0.000 | .987 | |
| CG (n = 16) | 93.8 ± 30.1 | 84.6 ± 32.4 | -1.106 | .286 | ||||
Values are presented as mean ± standard deviation.
ANOVA, analysis of variance; T×G, time-by-group interactions; ES, effect size; AST, aspartate transaminase; ALT, alanine aminotransferase; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; PSG, protein supplement group; CG, control group; Significance level at 0.05.